Dawn Terashita-Gastelum
Public Health & General Preventive Medicine · Los Angeles, CANPI 1962696146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Novo Nordisk.
Across 3 payments — averaging $121.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$365
Across 16 payments — averaging $107,913 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$1.7M
What the payments were for
- Food & beverage$365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $365 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$365 in reported general payments places this provider in the 70th percentile of 109 public health & general preventive medicine providers in California.
See all public health & general preventive medicine providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 334 | $22,933 |
| Yf-VaxYellow Fever Vaccine Live/Pf | 20 | $8,153 |
| Typhim ViTyphoid Vi Polysacch Vaccine | 13 | $2,714 |
| VaqtaHepatitis A Virus Vaccine/Pf | 13 | $2,573 |
| Azithromycin | 274 | $805 |
Paid to pharmacies, not to this prescriber.
Other public health & general preventive medicine in Los Angeles
- Douglas FryeLos Angeles$2K
- Keith EmmonsLos Angeles$121
- Steven GalsonThousand Oaks$594K
- Ryan ZaneSan Bernardino$97K
- Ross MillerBeverly Hills$65K
- Daniel CosgroveIndian Wells$61K
- Philp DarneySan Francisco$13K
- Karen StuderLoma Linda$9K
- George RutherfordSan Francisco$9K
- Kate HaggertySan Marcos$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.